AMAZE by AstraZeneca

ACCELERATING DIGITAL HEALTH SOLUTIONS TO IMPROVE OUTCOMES FOR PATIENTS WITH CHRONIC DISEASES

AstraZeneca is collaborating with Massachusetts General Hospital to leverage robust data and clinical best practices in order to create digital health solutions that address today’s most urgent healthcare challenges. Catalyzed by the COVID-19 pandemic and a shared mission to improve care for patients with chronic illness, this novel partnership is focused on creating and clinically validating patient-centric digital health solutions and establishing a new standard of care for chronic illness management outside of a clinical setting.

This work is being led by CIDH and utilizes AstraZeneca’s new AMAZE™ disease management platform in studies for heart failure and asthma management. These first two studies pilot AMAZE in a real-world setting with the goals of improving patient engagement, care-team communication, and clinical outcomes while reducing healthcare costs.

Through remote monitoring, AMAZE identifies at-risk patients and delivers insights to the clinical care team at the point of care to improve the management of complex patient populations. The digital platform, including a patient app and clinician dashboard, is intended to speed up the adoption of evidence-based clinical practice with the aim of continuously improving the standard of patient care and healthcare efficiency.

Following the successful conclusion of the heart failure and asthma studies, AstraZeneca and Mass General plan to expand the use of AMAZE across multiple chronic disease areas, reaching patients throughout the Mass General Brigham system, and beyond.